Hancock Jaffe Laboratories Inc WT (HJLIW) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:HJLIW

0.56
+0.07 (+13.41%)
Last: Sep 30, 2021, 08:00 PM

HJLIW Key Statistics, Chart & Performance

Key Statistics
Market Cap0
Revenue(TTM)N/A
Net Income(TTM)N/A
SharesN/A
FloatN/A
52 Week High0.8
52 Week Low0.04
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
HJLIW short term performance overview.The bars show the price performance of HJLIW in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

HJLIW long term performance overview.The bars show the price performance of HJLIW in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300 400

The current stock price of HJLIW is 0.56 null. In the past month the price increased by 60%. In the past year, price increased by 409.09%.

Hancock Jaffe Laboratories Inc WT / HJLIW Daily stock chart

HJLIW Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to HJLIW. When comparing the yearly performance of all stocks, HJLIW is one of the better performing stocks in the market, outperforming 99.13% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

HJLIW Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

HJLIW Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

HJLIW Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About HJLIW

Company Profile

Hancock Jaffe Laboratories, Inc. is involved in developing and manufacturing bioprosthetic medical devices to treat cardiac and vascular diseases. Its product candidates consists of the porcine tissue based VenoValve, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; CoreoGraft', a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery and a porcine tissue based heart valve, is an ideal candidate for pediatric aortic/mitral valve replacement. Hancock Jaffe Laboratories, Inc. is based in IRVINE, United States.

Company Info

Hancock Jaffe Laboratories Inc WT

Hancock Jaffe Laboratories Inc WT / HJLIW FAQ

What does HJLIW do?

Hancock Jaffe Laboratories, Inc. is involved in developing and manufacturing bioprosthetic medical devices to treat cardiac and vascular diseases. Its product candidates consists of the porcine tissue based VenoValve, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; CoreoGraft', a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery and a porcine tissue based heart valve, is an ideal candidate for pediatric aortic/mitral valve replacement. Hancock Jaffe Laboratories, Inc. is based in IRVINE, United States.


What is the stock price of Hancock Jaffe Laboratories Inc WT today?

The current stock price of HJLIW is 0.56 null. The price increased by 13.41% in the last trading session.


What is the dividend status of Hancock Jaffe Laboratories Inc WT?

HJLIW does not pay a dividend.


What is the ChartMill rating of Hancock Jaffe Laboratories Inc WT stock?

HJLIW has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Who owns Hancock Jaffe Laboratories Inc WT?

You can find the ownership structure of Hancock Jaffe Laboratories Inc WT (HJLIW) on the Ownership tab.